GE Healthcare launches global initiative on 10th anniversary of
12 October 2009
To commemorate the tenth anniversary of digital mammography and its
long standing commitment to fighting breast cancer, GE Healthcare has
created a digital wall of personal stories from those whose lives have
been touched by breast cancer, as well as doctors, scientists and
fundraisers who work tirelessly against the disease.
Similar to digital photography, digital mammography replaces the film
used in traditional mammography with digital files viewed and stored on
In addition to being the tenth anniversary of digital mammography, a
technology introduced by GE Healthcare in 1999, this October is Breast
Cancer Awareness Month.
Around 30 patients, survivors, fundraisers and medical professionals
from around the world are the foundation of the first phase of the GE
Healthcare’s wall. The company hopes that the wall will grow rapidly and
become a global platform for survivors, innovators and charities to
share their stories, provide additional information on technology
milestones and successes and empower others impacted by breast cancer.
“Our initiative shows that breast cancer is indiscriminate. It
affects women, and also men, irrespective of their age, nationality and
religion. We want people to get involved and share their story. Today,
they can do that by clicking the “submit your story” icon on the site
and share their experience, knowledge and hope with others,” said Wendy
Harris, Strategic Marketing Leader, Women’s Health at GE Healthcare.
“I hope to see it grow rapidly in size to become a definitive hub for
empowering stories; how survivors have fought and overcome the disease,
as well as profiling the doctors, and scientists who are working
tirelessly – often behind the scenes,” continued Harris.
In addition to this initiative, GE Healthcare is participating in
several breast cancer awareness events around the globe during the month
of October. Amongst others, on October 4, 2009, GE Healthcare France
joined forces with the Odyssea breast cancer race in Paris to educate
the general public on the disease and solutions where all funds raised
are being given in its entirety to the Institute Gustave- Roussy (IGR)
to conduct research.
In China, the Company is participating in a three year project in
Deyang, a city in the earthquake-stricken Sichuan province, to establish
a regional breast-cancer screening network to increase the access to
breast cancer screening, diagnosis and treatment, including remote
diagnosis for more rural areas. GE Healthcare also recently entered into
a research and development program to advance technologies for the early
detection of breast cancer with the Qatar Science & Technology Park
About GE Healthcare's pioneering development of advanced
GE Healthcare has been a leader in the field of breast cancer
detection through mammography devices since the 1960s. Today there are
approximately 17,700 GE Healthcare mammography systems in use worldwide.
GE Healthcare was the first company to introduce full-field digital
mammography (FFDM) in 1999. GE Healthcare estimates that since then,
more than 40 million examinations have been performed with its
diagnostic imaging technologies worldwide.
The company has spent 13 years and more than $100 million developing
the full-field digital mammography technology, GE Healthcare Senographe
systems, and continues to invest heavily in new cutting-edge
technologies to detect the pathology before the onset.
Approximately 3700 GE Healthcare Senographe digital systems are
currently being used in the world — more than 90% of them still work
with their original detector.
In August this year, healthcare technology research organization KLAS
ranked GE Healthcare’s Senographe DS as the best digital mammography
system on the US market today, based on a survey of healthcare
Through its own research as well as partnerships with other industry
innovators, GE Healthcare is continuing to develop advanced technologies
that could help improve detection and reduce unnecessary biopsies in the
future, including a magnetic resonance imaging (MRI) system specifically
designed for breast imaging and tomosynthesis — currently under clinical
investigation — which generates three-dimensional images.
1. Visit the digital wall of personal breast cancer stories at
Bookmark this page